EUVIMEDEUVIMED entdecken
Crossref

Tanshinone IIA attenuates osteoarthritis via inhibiting aberrant angiogenesis in subchondral bone

Hong-Zhou Li, Dong Han, Rui-Feng Ao, Zhi-Hai Cai, Guo-Zheng Zhu, Di-Zheng Wu, Jia-Wen Gao, Jing-Shen Zhuang, Chen Tu, Kai Zhao, Zhi-Yong Wu, Zhao-Ming Zhong

Archives of Biochemistry and Biophysics · 2024-03 · 753 · 109904

DOI: 10.1016/j.abb.2024.109904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024-03. Verfasst von Hong-Zhou Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Spine Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular, Abietanes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, Jiangxi Provincial Department of Education, Department of Health of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive angiogenesis in subchondral bone is a pathological feature of osteoarthritis (OA). Tanshinone IIA (TIIA), an active compound found in Salvia miltiorrhiza, demonstrates significant anti-angiogenic properties. However, the effect of TIIA on abnormal subchondral angiogenesis in OA is still unclear. This study aims to investigate the mechanism of TIIA in modulating subchondral bone angiogenesis during OA and assess its therapeutic potential in OA. Our findings demonstrate that TIIA attenuated articular cartilage degeneration, normalized subchondral bone remodeling, and effectively suppressed aberrant angiogenesis within subchondral bone in monosodium iodoacetate (MIA)-induced OA mice. Additionally, the angiogenesis capacity of primary CD31hiEmcnhi endothelial cells was observed to be significantly reduced after treatment with TIIA in vitro. Mechanically, TIIA diminished the proportion of hypertrophic chondrocytes, ultimately leading to a substantial reduction in the secretion of vascular endothelial growth factor A (VEGFA). The supernatant of hypertrophic chondrocytes promoted the tube formation of CD31hiEMCNhi endothelial cells, whereas TIIA inhibited this process. Furthermore, TIIA effectively suppressed the expression of vascular endothelial growth factor receptor 2 (VEGFR2) along with its downstream MAPK pathway in CD31hiEmcnhi endothelial cells. In conclusion, our data indicated that TIIA could effectively inhibit the abnormal angiogenesis in subchondral bone during the progression of OA by suppressing the VEGFA/VEFGR2/MAPK pathway. These findings significantly contribute to our understanding of the abnormal angiogenesis in OA and offer a promising therapeutic target for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCartilage, ArticularAbietanesMiceAnimalsVascular Endothelial Growth Factor AEndothelial CellsAngiogenesis

Stichwörter der Autor:innen

Aberrant angiogenesisCD31(hi)Emcn(hi) endothelial cellsOsteoarthritisTanshinone IIAVEGFA/VEGFR2/MAPK

Substanzen

Vascular Endothelial Growth Factor AtanshinoneAbietanes

Autor:innen und Institutionen

  • Division of Spine Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Orthopaedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Electronic address: zhaokai@gmu.edu.cn.
  • Department of Traditional Chinese Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: 11100227@smu.edu.cn.
  • Division of Spine Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: zhongzm@smu.edu.cn.

Förderung

  • Natural Science Foundation of Guangdong Province
  • Jiangxi Provincial Department of Education
  • Department of Health of Jiangxi Province
  • Health Commission of Jiangxi Province

Zitieren

APA

Li, H. Z., Han, D., Ao, R. F., Cai, Z. H., Zhu, G. Z., Wu, D. Z., Gao, J. W., Zhuang, J. S., Tu, C., Zhao, K., Wu, Z. Y., & Zhong, Z. M. (2024). Tanshinone IIA attenuates osteoarthritis via inhibiting aberrant angiogenesis in subchondral bone. Archives of Biochemistry and Biophysics, 753, 109904. https://doi.org/10.1016/j.abb.2024.109904

Vancouver

Li HZ, Han D, Ao RF, Cai ZH, Zhu GZ, Wu DZ, et al. Tanshinone IIA attenuates osteoarthritis via inhibiting aberrant angiogenesis in subchondral bone. Archives of Biochemistry and Biophysics. 2024;753:109904. doi:10.1016/j.abb.2024.109904

BibTeX
@article{Li2024,
  author = {Li, Hong-Zhou and Han, Dong and Ao, Rui-Feng and Cai, Zhi-Hai and Zhu, Guo-Zheng and Wu, Di-Zheng and Gao, Jia-Wen and Zhuang, Jing-Shen and Tu, Chen and Zhao, Kai and Wu, Zhi-Yong and Zhong, Zhao-Ming},
  title = {Tanshinone IIA attenuates osteoarthritis via inhibiting aberrant angiogenesis in subchondral bone},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  volume = {753},
  pages = {109904},
  doi = {10.1016/j.abb.2024.109904}
}
Kostenlos starten →